Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Uveal Melanoma.
Shoushtari AN, Carvajal RD. Shoushtari AN, et al. Cancer Treat Res. 2016;167:281-93. doi: 10.1007/978-3-319-22539-5_12. Cancer Treat Res. 2016. PMID: 26601868 Review.
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.
Francis JH, Habib LA, Abramson DH, Yannuzzi LA, Heinemann M, Gounder MM, Grisham RN, Postow MA, Shoushtari AN, Chi P, Segal NH, Yaeger R, Ho AL, Chapman PB, Catalanotti F. Francis JH, et al. Among authors: shoushtari an. Ophthalmology. 2017 Dec;124(12):1788-1798. doi: 10.1016/j.ophtha.2017.05.038. Epub 2017 Jul 12. Ophthalmology. 2017. PMID: 28709702 Free PMC article.
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor.
Kelly CM, Shoushtari AN, Qin LX, D'Angelo SP, Dickson MA, Gounder MM, Keohan ML, Mcfadyen C, Sjoberg A, Singer S, DeMatteo RP, Hwang S, Heinemann MH, Francis JH, Antonescu CR, Chi P, Tap WD. Kelly CM, et al. Among authors: shoushtari an. Invest New Drugs. 2019 Apr;37(2):282-290. doi: 10.1007/s10637-018-0648-z. Epub 2018 Aug 13. Invest New Drugs. 2019. PMID: 30101387 Free PMC article. Clinical Trial.
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071.
Piperno-Neumann S, Larkin J, Carvajal RD, Luke JJ, Schwartz GK, Hodi FS, Sablin MP, Shoushtari AN, Szpakowski S, Chowdhury NR, Brannon AR, Ramkumar T, de Koning L, Derti A, Emery C, Yerramilli-Rao P, Kapiteijn E. Piperno-Neumann S, et al. Among authors: shoushtari an. Mol Cancer Ther. 2020 Apr;19(4):1031-1039. doi: 10.1158/1535-7163.MCT-19-0098. Epub 2020 Feb 6. Mol Cancer Ther. 2020. PMID: 32029634 Clinical Trial.
Isolated Abducens Nerve Palsy Following Pembrolizumab.
Jaben KA, Francis JH, Shoushtari AN, Abramson DH. Jaben KA, et al. Among authors: shoushtari an. Neuroophthalmology. 2019 Jan 16;44(3):182-185. doi: 10.1080/01658107.2019.1566385. eCollection 2020 Jun. Neuroophthalmology. 2019. PMID: 32395170 Free PMC article.
Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.
Hitchman TD, Bayshtok G, Ceraudo E, Moore AR, Lee C, Jia R, Wang N, Pachai MR, Shoushtari AN, Francis JH, Guan Y, Chen J, Chang MT, Taylor BS, Sakmar TP, Huber T, Chi P, Chen Y. Hitchman TD, et al. Among authors: shoushtari an. Clin Cancer Res. 2021 Mar 1;27(5):1476-1490. doi: 10.1158/1078-0432.CCR-20-2860. Epub 2020 Nov 23. Clin Cancer Res. 2021. PMID: 33229459 Free PMC article.
133 results